Page last updated: 2024-11-04

3-oxoadipic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-oxoadipic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-oxoadipic acid : An oxo dicarboxylic acid consisting of adipic acid having a single oxo group at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID93
CHEBI ID37440
SCHEMBL ID218098
MeSH IDM0088908

Synonyms (32)

Synonym
beta-ketoadipic acid
CHEBI:37440
3-oxohexanedioic acid
beta-oxoadipic acid
nsc18511
nsc-18511
beta-ketoadipate
C00846
689-31-6
3-oxoadipic acid
b-oxoadipic acid
3-oxo-adipic acid
LMFA01170096
3-oxo-hexanedioic acid
nsc 18511
1379jra56f ,
unii-1379jra56f
hexanedioic acid, 3-oxo-
3-ketoadipic
FT-0616295
.beta.-oxoadipic acid
.beta.-ketoadipic acid
3-ketoadipic acid
SCHEMBL218098
DTXSID30218974
RTGHRDFWYQHVFW-UHFFFAOYSA-N
b-ketoadipate
b-ketoadipic acid
b-oxoadipate
beta-oxoadipate
Q27117141
STARBLD0045478

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Strategies that may enhance substrate bioavailability such as surfactant production and chemotactic responses toward aromatic compounds were confirmed."( New Findings on Aromatic Compounds' Degradation and Their Metabolic Pathways, the Biosurfactant Production and Motility of the Halophilic Bacterium Halomonas sp. KHS3.
Corti Monzón, G; Herrera Seitz, MK; Murialdo, SE; Nisenbaum, M, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
oxo dicarboxylic acidAny dicarboxylic acid carrying one or more oxo groups.
dicarboxylic fatty acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (91)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (25.27)18.7374
1990's20 (21.98)18.2507
2000's18 (19.78)29.6817
2010's26 (28.57)24.3611
2020's4 (4.40)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.04 (24.57)
Research Supply Index4.53 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.26%)6.00%
Case Studies1 (1.09%)4.05%
Observational0 (0.00%)0.25%
Other88 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]